INTRODUCTION Despite major advances in rheumatoid arthritis (RA) treatment and the improved outcomes that have been associated with the expanding number of disease-modifying antirheumatic drugs (DMARDs) available, a substantial number of patients are refractory to multiple biologics, highlighting a persistent unmet need in patients with RA.1-4 The term “refractory RA” (reRA) characterizes a state of persistent inflammation, symptoms, or disease activity despite exposure to multiple advanced...
Sofia Pedro
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Sofia
Contact Sofia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack